Vanda Pharmaceuticals, Inc. (VNDA)
8.16
+2.40
(+41.67%)
USD |
NASDAQ |
Feb 23, 16:00
8.22
+0.06
(+0.74%)
After-Hours: 19:59
Vanda Pharmaceuticals Research and Development Expense (Quarterly) : 29.01M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Eli Lilly & Co. | 3.802B |
| Axsome Therapeutics, Inc. | 40.04M |
| AnaptysBio, Inc. | 31.27M |
| SELLAS Life Sciences Group, Inc. | 4.216M |
| Protagenic Therapeutics, Inc. | 0.2732M |